SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Crystals of single chirality via non-equilibrium routes

This project aims to develop a novel method for converting racemic compounds into desired enantiomers by manipulating crystal stability under non-equilibrium conditions, impacting pharmaceutical production.

Subsidie
€ 2.415.625
2022

Projectdetails

Introduction

The molecular building blocks of life are of only one handedness. Consequently, pharmaceuticals and other bioactive molecules also need to be of one handedness. When such enantiomers crystallize in separate crystals, isolation of the desired handedness is relatively straightforward.

Problem Statement

Unfortunately, most enantiomers (90-95%) are thermodynamically more stable as racemic compounds with both enantiomers in the crystallographic unit cell, which impedes any such separations. There are currently no methods to systematically overcome this major bottleneck, thus hindering simple routes towards many essential enantiopure molecules.

Proposal Overview

This proposal is aimed at overcoming this fundamental challenge by establishing new principles to turn racemic compounds into molecules of a desired handedness by liberating them from their thermodynamic constraints.

Methodology

To achieve this ambitious goal, we introduce a revolutionary new approach: manipulating the stability of crystals by subjecting mixtures of crystals to non-equilibrium conditions. Building upon our preliminary work, we hypothesize that growth/dissolution rates can be manipulated by selecting crystallization conditions such that the thermodynamically stable racemic compound is converted into the desired enantiomer.

Objectives

To achieve this ambitious goal, the main objectives of this proposal are to:

  1. Demonstrate the proof-of-principle.
  2. Identify the essential parameters.
  3. Understand the mechanism behind this methodology.

Expected Outcomes

The results of this ERC Consolidator will hold direct relevance for our fundamental understanding of non-equilibrium conditions in reactive crystallizations. The outcomes of this research will immediately impact our ability to produce molecules of single handedness.

Conclusion

Ultimately, this breakthrough holds the potential to disrupt the pharmaceutical industry by offering versatile, sustainable, and simple routes towards essential enantiomerically pure building blocks that are crucial in our daily lives.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.415.625
Totale projectbegroting€ 2.415.625

Tijdlijn

Startdatum1-9-2022
Einddatum31-8-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • STICHTING NEDERLANDSE WETENSCHAPPELIJK ONDERZOEK INSTITUTENpenvoerder

Land(en)

Netherlands

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Advanced Molecular ENantiodiscrimination

The AMEN project aims to develop scalable chiral microreactor technology for the selective production of pharmaceutical enantiomers, ensuring safety and efficacy in drug formulations.

ERC Proof of...€ 150.000
2024
Details

Catalytic Light-induced Deracemization

The CALIDE project aims to develop innovative photocatalytic methods for the efficient conversion of racemates into enantiomerically pure compounds using light, reducing waste in chiral synthesis.

ERC Advanced...€ 2.447.299
2025
Details

Enantioselective screw-dislocation-mediated growth of chiral nanocrystals

This project aims to investigate the role of screw dislocations in the chiral shape formation of nanocrystals, enhancing our understanding of crystallization and enabling novel applications in material design.

ERC Starting...€ 1.500.000
2023
Details

Coherent Control of Chiral Molecules

The project aims to generate an enantiomer-pure beam of chiral molecules from a racemic sample using advanced quantum state preparation and detection techniques.

ERC Starting...€ 1.809.735
2024
Details

Heterogeneous Asymmetric Nanocluster-catalysis Design

The HAND project aims to develop atomically precise chiral nanoclusters for heterogeneous asymmetric catalysis to achieve enantioselectivity and enhance understanding of chirality at surfaces.

ERC Consolid...€ 1.993.224
2024
Details
ERC Proof of...

Advanced Molecular ENantiodiscrimination

The AMEN project aims to develop scalable chiral microreactor technology for the selective production of pharmaceutical enantiomers, ensuring safety and efficacy in drug formulations.

ERC Proof of Concept
€ 150.000
2024
Details
ERC Advanced...

Catalytic Light-induced Deracemization

The CALIDE project aims to develop innovative photocatalytic methods for the efficient conversion of racemates into enantiomerically pure compounds using light, reducing waste in chiral synthesis.

ERC Advanced Grant
€ 2.447.299
2025
Details
ERC Starting...

Enantioselective screw-dislocation-mediated growth of chiral nanocrystals

This project aims to investigate the role of screw dislocations in the chiral shape formation of nanocrystals, enhancing our understanding of crystallization and enabling novel applications in material design.

ERC Starting Grant
€ 1.500.000
2023
Details
ERC Starting...

Coherent Control of Chiral Molecules

The project aims to generate an enantiomer-pure beam of chiral molecules from a racemic sample using advanced quantum state preparation and detection techniques.

ERC Starting Grant
€ 1.809.735
2024
Details
ERC Consolid...

Heterogeneous Asymmetric Nanocluster-catalysis Design

The HAND project aims to develop atomically precise chiral nanoclusters for heterogeneous asymmetric catalysis to achieve enantioselectivity and enhance understanding of chirality at surfaces.

ERC Consolidator Grant
€ 1.993.224
2024
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Chiral separation of molecules enabled by enantioselective optical forces in integrated nanophotonic circuits

CHIRALFORCE aims to revolutionize enantiomer separation for drug discovery using silicon-based integrated waveguides and chiral optical forces for rapid, cost-effective processing.

EIC Pathfinder€ 3.263.726
2022
Details
EIC Pathfinder

Chiral separation of molecules enabled by enantioselective optical forces in integrated nanophotonic circuits

CHIRALFORCE aims to revolutionize enantiomer separation for drug discovery using silicon-based integrated waveguides and chiral optical forces for rapid, cost-effective processing.

EIC Pathfinder
€ 3.263.726
2022
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.